Synthetic growth hormone-releasing hormone (GHRH) analog, FDA-approved as Egrifta® for HIV-associated lipodystrophy. Researched for visceral fat reduction.
Peptigrity tracks Tesamorelin across 219 shops with 238 independent lab tests and an average HPLC purity of 99.34%.
Synthetic growth hormone-releasing hormone (GHRH) analog, FDA-approved as Egrifta® for HIV-associated lipodystrophy. Researched for visceral fat reduction.
Every submitted test helps the community verify purity across brands. Free, fast, independent.